홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

락톤

Trimethylpsoralen

HCID 5585
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
3902-71-4
표준 SMILES
Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1
InChIKey
FMHHVULEAZTJMA-UHFFFAOYSA-N
분자식
C14H12O3
평균 분자량
228.24 g/mol
단동위원소 질량
228.07864424

개요

Trioxsalen is 7H-Furo[3,2-g]chromen-7-one in which positions 2, 5, and 9 are substituted by methyl groups. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered orally in conjunction with UV-A for phototherapy treatment of vitiligo. After photoactivation it creates interstrand cross-links in DNA, inhibiting DNA synthesis and cell division, and can lead to cell injury; recovery from the cell injury may be followed by increased melanisation of the epidermis. It has a role as a photosensitizing agent and a dermatologic drug.

이름 및 식별자

우선 이름
Trimethylpsoralen
IUPAC
2,5,9-trimethylfuro[3,2-g]chromen-7-one
현지명
락톤
영어명
TRIOXSALEN
분자식
C14H12O3
분자량
228.24

이름 및 동의어

trioxsalen3902-71-4TrioxysalenTrimethylpsoralen4,5',8-TrimethylpsoralenTrioxisalenoTrioxysalene2',4,8-TrimethylpsoralenTrioxysalenumNSC710472,5,9-trimethylfuro[3,2-g]chromen-7-oneTmp (psoralen)
이름 더 보기
락톤트라이옥살렌LACTONENSC-71047TrioxalenTrioxsaleTrixsalenrioxsalenTRISORALENElder 8011
DTXSID3023716NSC 710477H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl-Y6UY8OV51T2,5,9-Trimethyl-7H-furo(3,2-g)(1)benzopyran-7-one7H-Furo(3,2-g)(1)benzopyran-7-one, 2,5,9-trimethyl-2,5,9-Trimethyl-7H-furo[3,2-g][1]benzopyran-7-oneDTXCID403716

데이터베이스 식별자

CAS
3902-71-4
PubChem CID
5585
DTXSID
DTXSID3023716
ChEMBL
CHEMBL1475
ChEBI
CHEBI:28329
UNII
Y6UY8OV51T
EC Number

물성

구조 계산 물성

XLogP
3
극성 표면적
39.4 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
3
회전 가능 결합 수
0
무거운 원자 수
17
형식 전하
0
복잡도
374

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15
SpringerMaterials PropertiesFusion temperature
LogP3.25
Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physical DescriptionSolid
Collision Cross Section · 2건

147.4 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

146.69 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
229 · 229-231 °C(lit.)
끓는 점
310.05 °C · 310.05°C (rough estimate)
밀도
1.2196 · 1.2196 (rough estimate)
굴절률
1.5557 · 1.5557 (estimate)
저장 조건
-20 °C · -20°C
용해도
DMSO: 용해될 수 있다
물리적 상태

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]

P203, P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P318, P321, P363, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Other Safety InformationIMAP assessments - 7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl-: Human health tier I assessment
Hazard Classes and CategoriesSkin Corr. 1B (100%)

독성 정보

Carcinogen Classification · 5건

4,5',8-Trimethylpsoralen

Group 3: Not classifiable as to its carcinogenicity to humans

Volume 40: (1986) Some Naturally Occurring and Synthetic Food Components, Furocoumarins and Ultraviolet Radiation

1987

1987

안전 데이터

wgk
2
tsca
TSCA listed
rtecs
LV1576000
ridadr
UN 1759 8/PG 1
HS 번호
29322985
risk_code
34-40
hazard_code
C
safety_code
26-36/37/39-45

화학 및 산업

약리 정보

ATC Code · 4건

D - Dermatologicals

D - Dermatologicals

QD - Dermatologicals

QD - Dermatologicals

PharmacodynamicsTrioxsalen ispharmacologically inactive but when exposed to ultraviolet radiation or sunlight it is converted to its active metabolite to produce a beneficial reaction affecting the diseased tissue.
Mechanism of ActionAfter photoactivation it creates interstrand cross-links in DNA, which can cause programmed cell death.
FDA Pharmacological Classification · 5건

Y6UY8OV51T

TRIOXSALEN

Established Pharmacologic Class [EPC] - Psoralen

Chemical Structure [CS] - Psoralens

Trioxsalen is a Psoralen.

MeSH Pharmacological Classification · 1건

Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.

Cellular LocationsCytoplasm

용도 및 제조

General Manufacturing Information7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl-: INACTIVE

응용 분야

용도Trioxsalen has been used: to induce small deletion mutations in worms in combination with ultraviolet A (UVA) to induce interstrand crosslinks (ICLs) in DNA for the preparation and photoactivation of trimethyl psoralen

관련 반응

2건
반응 기록 만들기
HRID 225031 반응식
HRID 225031생성물로
HRID 1855734 반응식
HRID 1855734생성물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
223-459-0
Nikkaji
J3.411H
가루
색상
하얀색
Merck
14 · 14,9735
BRN
221723 · 221723
InChI
1S/C14H12O3/c1-7-4-12(15)17-14-9(3)13-10(6-11(7)14)5-8(2)16-13/h4-6H,1-3H3
InChIKey
FMHHVULEAZTJMA-UHFFFAOYSA-N
SMILES
Cc1cc2cc3C(C)=CC(=O)Oc3c(C)c2o1
EPA
7 H-Furo[3,2-g][1]benzopyran-7-one, · 7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl- (3902-71-4)

화학적 성질

White to slightly beige crystalline powder

포장분류
III
위험 등급
8
기존화학 물질
KE-34519
F 고인화성물질
8-10
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationEye Dam. 1Muta. 2Skin Corr. 1B
스토리지 클래스
8A - Combustible corrosive hazardous materials

상·하류 제품 정보

상류 원료

아세트초산에틸에틸알코올아세톤탄산 칼륨1,3- 벤젠, 2- 메틸설파믹산메틸알콜수산화나트륨N,N-디에틸아닐린황산마그네슘1,2,3-트리브로모프로판황산 칼륨염산나트륨2H-1-Benzopyran-2-one, 7-[(2-chloro-2-propenyl)oxy]-4,8-dimethyl-7-Allyloxy-4,8-dimethyl-chromen-2-one6-allyl-7-hydroxy-4,8-dimethyl-2H-chromen-2-one7-하이드록시-4,8-디메틸쿠마린
추가 설명 · 1건

정의ChEBI: 7H-Furo[3,2-g]chromen-7-one in which positions 2, 5, and 9 are substituted by methyl groups. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered orally in conjunction with UV-A for phot therapy treatment of vitiligo. After photoactivation it creates interstrand cross-links in DNA, inhibiting DNA synthesis and cell division, and can lead to cell injury; recovery from the cell injury may be followed by increased melanisation of the epidermi .